ARTICLE | Clinical News
Malaria vaccine: Phase Ib data
July 12, 2010 7:00 AM UTC
In a Tanzanian Phase Ib trial in 40 healthy volunteers as young as 5 years of age, 2 injections of Mymetics' malaria vaccine were well tolerated and induced specific, long-lasting antibody responses a...